[
    [
        {
            "time": "",
            "original_text": "我国首个新冠mRNA疫苗启动临床试验 沃森生物、艾博生物联合研发",
            "features": {
                "keywords": [
                    "新冠",
                    "mRNA疫苗",
                    "临床试验",
                    "沃森生物",
                    "艾博生物"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "我国首个新冠mRNA疫苗启动临床试验 沃森生物、艾博生物联合研发",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "国内首个！沃森生物mRNA新冠疫苗开始临床试验",
            "features": {
                "keywords": [
                    "国内首个",
                    "mRNA新冠疫苗",
                    "临床试验",
                    "沃森生物"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "国内首个！沃森生物mRNA新冠疫苗开始临床试验",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "我国首个新冠mRNA疫苗获批临床，沃森生物、苏州生物医药企业参与共同研制",
            "features": {
                "keywords": [
                    "新冠",
                    "mRNA疫苗",
                    "临床试验",
                    "沃森生物",
                    "苏州生物医药"
                ],
                "sentiment_score": 0.88,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "我国首个新冠mRNA疫苗获批临床，沃森生物、苏州生物医药企业参与共同研制",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "我国首个新冠mRNA疫苗获批临床 沃森生物、苏州生物医药企业参与共同研制",
            "features": {
                "keywords": [
                    "新冠",
                    "mRNA疫苗",
                    "临床试验",
                    "沃森生物",
                    "苏州生物医药"
                ],
                "sentiment_score": 0.87,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "我国首个新冠mRNA疫苗获批临床 沃森生物、苏州生物医药企业参与共同研制",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        }
    ]
]